D. M. Rudkevich and H. Xu
FULL PAPER
(Applied Biosystems). HRMS MALDI spectra were obtained on an Ion
Spec Ultima FTMS. Elemental analyses were performed on a Perkin-
Elmer 2400 CHN analyzer. SEM images were obtained by using a JEOL
35C microscope.
30.4, 27.6, 26.6, 26.2, 22.9, 22.7, 14.5, 10.7, 10.6 ppm; FTIR (KBr): n˜ =
3339, 2932, 2859, 1659, 1599, 1562, 1468, 1213 cmꢁ1; ESI-MS: m/z: calcd
for C75H115F3N10O11: 1389; found: 1389.
The TFA salt (0.50 g, 0.36 mmol) in CHCl3 (100 mL) was washed with
aqueous 10% NaOH (250 mL), then evaporated and dried in high
vacuo. 1H NMR ([D6]DMSO): d=8.18 (t, J=5 Hz, 1H), 8.05 (brs, 1H),
8.00 (brs, 1H), 7.85 (brs, 2H), 6.80 (2s, 4H), 6.61 (s, 4H), 5.88 (m,
2H), 5.80 (t, J=5.5 Hz, 2H), 4.36 (s, 2H), 4.32 (d, J=12.8 Hz, 2H), 4.26
(d, J=12.8 Hz, 2H), 3.76 (t, J=7.8 Hz, 4H), 3.69 (t, J=7.8 Hz, 2H), 3.22
(m, 2H), 2.99 (m, 12H), 2.53 (t, J=6.0 Hz, 2H), 1.9–1.7, 1.6–1.4, 1.4–1.3,
1.3–1.1, 1.0–0.8 ppm (5m, 67H); 13C NMR ([D6]DMSO): d=169.3,
155.8, 155.7, 151.2, 150.7, 150.4, 135.4, 135.1, 135.0, 134.5, 134.2, 134.1,
118.8, 118.7, 118.5, 118.47, 77.3, 76.5, 74.8, 31.6, 30.4, 26.7, 22.9, 22.7, 14.5,
All experiments with moisture- and/or air-sensitive compounds were car-
ried out under a dried nitrogen atmosphere. For column chromatography,
Silica Gel 60 was used (Sorbent Technologies, Inc.; 200–425 mesh).
Parent tetrahydroxycalix[4]arene[27] and other calixarene precursors[15]
were prepared according to the published procedures. Molecular model-
ing was performed using commercial MacroModel 7.1with Amber*
Force Field.
Calix[4]arene tetraurea acid (3): n-Hexyl isocyanate (1.78 mL,
12.25 mmol) was added to a solution of the previously described tetra-
aminocalix[4]arene[15] (2.0 g, 2.45 mmol) in dry CH2Cl2 (80 mL), and the
reaction mixture was stirred at RT for 4 h. The solvent was removed in
vacuo, and the residue was triturated with hexane to yield the tetraurea
ester as a tan powder (2.72 g, 2.25 mmol, 92%). 1H NMR ([D6]DMSO):
d=8.06 (s, 1H), 8.05 (s, 1H), 7.81 (s, 2H), 6.87 (s, 2H), 6.84 (s, 2H), 6.53
(m, 4H), 5.88 (m, 2H), 5.69 (t, J=5.0 Hz, 2H), 4.71(s, 2H), 4.50 (d, J=
13.3 Hz, 2H), 4.29 (d, J=12.37 Hz, 2H), 4.12 (q, J=7.3 Hz, 2H), 3.75 (t,
J=7.8 Hz, 2H), 3.68 (t, J=7.8 Hz, 2H), 3.62 (t, J=7.8 Hz, 2H), 3.15–2.90
(m, 12H), 1.92 (m, 2H), 1.82 (m, 4H), 1.5–0.80 ppm (6m, 56H).
10.6 ppm; FTIR (KBr): n˜ =3344, 2930, 2858, 1654, 1559, 1475, 1213 cmꢁ1
;
ESI MS: m/z: calcd for C73H114N10O9: 1275; found: 1276 [M+H]+, 2552
[2M+2H]+.
Di-l-lysine (6):[28,18] To a stirred and ice-cooled solution of N-e-Cbz-l-
lysine TFA salt (1.0 g, 2.45 mmol) in DMF (30 mL), Et3N (0.34 mL,
2.45 mmol) was added. Then, after 15 min, acid N-a-Boc-N-e-Cbz-l-
lysine (0.93 g, 2.45 mmol), HOBt (0.66 g, 4.90 mmol), and DCC (1.01 g,
4.90 mmol) were successively added. The mixture was stirred for 30 min
at 08C and for 24 h at RT, then filtered, concentrated under reduced
pressure, diluted with EtOAc (200 mL), and washed successively with
NaHSO4 (1n, 450 mL), water (350 mL), NaHCO3 (1n, 450 mL),
and again with water (350 mL). The organic layer was then dried over
anhydrous Na2SO4 and evaporated. The residue was separated chromato-
graphically on silica gel eluting with THF/hexanes (2:3) to afford the de-
sired Cbz-protected dipeptide (1.14 g, 71%). 1H NMR ([D6]DMSO): d=
8.10 (d, J=7.3 Hz, 1H), 7.34 (m, 10H), 7.22 (t, J=5.5 Hz, 2H), 6.78 (d,
J=8.0 Hz, 1H), 4.99 (s, 4H), 4.20 (m, 1H), 3.90 (m, 1H), 3.59 (s, 3H),
2.96 (m, 4H), 1.32 (s, 9H), 1.8–1.1 ppm (4 m, 12H); 13C NMR (CDCl3):
d172.8, 172.7, 156.8, 156.0, 136.7, 136.6, 128.6, 128.57, 128.3, 128.2, 128.2,
80.1, 66.8, 66.7, 54.1, 52.4, 52.1, 40.5, 32.2, 31.6, 29.4, 29.2, 28.4, 22.6,
A mixture of the tetraurea ester (1.5 g, 1.2 mmol) and KOH (0.67 g,
12.0 mmol) in THF/H2O, (5:1, 60 mL) was placed under reflux overnight,
after which H2O (60 mL) was added, and the pH was adjusted to 2 with
aqueous HCl (1m). The product was extracted with CHCl3 (360 mL),
the organic layer was dried over Na2SO4, evaporated, and recrystallized
from MeOH to give tetraurea acid 3 as a yellowish powder (1.13 g,
80%). M.p. >3008C; 1H NMR ([D6]DMSO): d=8.07 (s, 1H), 8.03 (s,
1H), 7.83 (s, 2H), 6.87 (s, 4H), 6.59 (s, 4H), 5.88 (m, 2H), 5.72 (t, J=
5.0 Hz, 2H), 4.56 (s, 2H), 4.43 (d, J=12.6 Hz, 2H), 4.27 (d, J=12.6 Hz,
2H), 3.76 (t, J=7.8 Hz, 2H), 3.69 (t, J=7.8 Hz, 2H), 3.67 (t, J=7.8 Hz,
2H), 3.01 (m, 8H), 2.95 (m, 4H), 1.95–1,75(m, 6H), 1.5–1.1 (m, 32H),
1.0–0.8 ppm (m, 21H); 13C NMR ([D6]DMSO): d=171.5, 155.8, 151.1,
150.4, 150.2, 135.6, 135.3, 135.1, 134.8, 134.3, 134.1, 118.7, 77.5, 77.2, 71.2,
31.7, 30.4, 30.3, 26.7, 23.1, 23.0, 22.7, 14.4, 10.8, 10.5 ppm; FTIR (KBr):
22.3 ppm; FTIR (KBr): n˜ =3359, 3036, 2948, 1699, 1544, 1259 cmꢁ1
.
A solution of the Cbz-protected dipeptide (0.2 g, 0.30 mmol) in CH3OH
(10 mL) was treated with 10% Pd/C (20 mg) and stirred under an H2 at-
mosphere for 6 h. The mixture was filtered through Celite and concen-
trated under reduced pressure to give product 6 as an oil (0.11 g, 94%).
1H NMR ([D6]DMSO): d=8.28 (d, J=7.3 Hz, 1H), 6.86 (d, J=8.5 Hz,
1H), 4.22 (m, 1H), 3.93 (m, 1H), 3.62 (s, 3H), 2.72 (t, J=7.1Hz, 4H),
1.36 (s, 9H), 2.0–1.0 ppm (m, 12H); MALDI-TOF MS: m/z: calcd for
C18H36N4O5: 388.5; found: 388.8 [M]+.
n˜ =3376, 3333, 2961, 2931, 2858, 1761, 1654, 1558, 1478, 1213 cmꢁ1
;
MALDI-FTMS: m/z: calcd for C67H101N8O10
1177.7632 [M+H]+.
:
1177.7635; found:
Calixarene (1): N-Boc-1,6-diaminohexane (0.38 mL, 1.68 mmol), DCC
(0.35 g, 1.68 mmol), HOBt (0.23 g, 1.68 mmol), and Et3N (0.23 mL,
1.68 mmol) were added to a stirred and ice-cooled solution of 3 (1.0 g,
0.84 mmol) in DMF (30 mL). The mixture was stirred for 30 min at 08C
and for 24 h at RT, then filtered, concentrated in vacuo, diluted with
CHCl3, and washed successively with NaHSO4 (1n, 4100 mL), water
(3100 mL), NaHCO3 (1n, 4100 mL), and again with water (3
100 mL). The organic layer was then dried over anhydrous Na2SO4 and
evaporated. The residue was separated chromatographically on silica gel
eluting with CHCl3/CH3OH (95:5) to afford the N-Boc-protected amine
1 as a colorless solid (0.84 g, 72%). M.p. 1858C (decomp); 1H NMR
([D6]DMSO): d=8.17 (t, J=5.7 Hz, 1H), 8.02 (brs, 1H), 7.98 (brs, 1H),
7.83 (brs, 2H), 6.81(s, 2H), 6.79 (s, 2H), 6.76 (t, J=5.5 Hz, 1H), 6.62
(brs, 4H), 5.82 (m, 2H), 5.77 (t, J=5.3 Hz, 2H), 4.35 (s, 2H), 4.33 (d, J=
12.6 Hz, 2H), 4.27 (d, J=12.6 Hz, 2H), 3.76 (t, J=7.3 Hz, 4H), 3.72 (t,
J=7.3 Hz, 2H), 3.24 (m, 2H), 3.00 (m, 12H), 2.91 (m, 2H), 1.36 (s, 9H),
1.9–0.8 ppm (5m, 71H); 13C NMR ([D6]DMSO): d=169.2, 156.1,
155.74, 155.7, 151.2, 150.7, 150.3, 135.4, 135.1, 135.0, 134.5, 134.2, 134.1,
118.7, 118.4, 77.8, 77.3, 76.5, 74.8, 31.6, 30.4, 28.83, 28.8, 26.7, 23.0, 22.9,
22.7, 14.5, 10.63, 10.6 ppm; FTIR (KBr): n˜ =3329, 2928, 2852, 1628, 1559,
Biscalixarene (5): Calixarene tetraurea acid 3 (1.0 g, 0.84 mmol), EDCI
(0.32 g, 1.68 mmol), and HOBt (0.23 g, 1.68 mmol) were added to a stir-
red and ice-cooled solution of dipeptide 6 (0.16 g, 0.42 mmol) in DMF
(30 mL). The mixture was stirred for 30 min at 08C and for 24 h at RT,
filtered, concentrated, diluted with CHCl3, and washed with water (3
100 mL). The organic layer was then dried over anhydrous Na2SO4 and
evaporated. The residue was separated chromatographically on silica gel
eluting with CHCl3/CH3OH (9.5:0.5) to afford calix dipeptide 5 (0.64 g,
56%). M.p. >188C (decomp); 1H NMR ([D6]DMSO): d=8.19 (m, 2H),
8.12 (d, J=7.8 Hz, 1H), 8.02 (s, 1H), 8.01 (s, 1H), 7.97 (s, 1H), 7.96 (s,
1H), 7.81 (s, 2H), 7.80 (s, 2H), 6.79 (s, 2H), 6.78 (s, 4H), 6.77 (s, 2H),
6.59 (s, 4H), 6.58 (s, 4H), 5.84 (m, 4H), 5.76 (m, 4H), 4.33 (brs, 4H),
4.30 (d, J=12.4 Hz, 4H), 4.23 (d, J=12.4 Hz, 4H), 3.91 (m, 1H), 3.72 (t,
J=6.9 Hz, 8H), 3.68 (t, J=6.9 Hz, 4H), 3.58 (s, 3H), 3.20 (m, 4H), 3.08–
2.90 (m, 24H), 1.34 (s, 9H), 1.9–0.8 ppm (6m, 130H); 13C NMR
([D6]DMSO): d=173.0, 172.9, 169.3, 155.74, 155.7, 151.25, 151.2, 150.7,
150.3, 135.3, 135.16, 135.1, 135.0, 134.5, 134.46, 134.2, 134.1, 134.0, 118.8,
118.72, 118.5, 118.4, 78.5, 77.3, 76.5, 74.8, 54.5, 52.3, 32.3, 31.6, 31.4, 31.2,
30.4, 30.1, 29.9, 28.7, 26.7, 23.6, 23.4, 23.0, 22.9, 22.7, 14.5, 10.6 ppm;
1476, 1213 cmꢁ1
.
A solution of the N-Boc-protected 1 (0.5 g, 0.36 mmol) in THF (15 mL)
was treated with TFA (5 mL) and stirred at RT for 2 h. The reaction mix-
ture was concentrated in vacuo to afford the pure TFA salt of 1 (0.47 g,
93%). 1H NMR ([D6]DMSO): d=8.18 (t, J=5.5 Hz, 1H), 8.05 (s, 1H),
7.99 (s, 1H), 7.84 (s, 2H), 6.80 (s, 2H), 6.63 (s, 2H), 6.60 (s, 2H), 5.88 (m,
2H), 5.78 (t, J=5.5 Hz, 2H), 4.37 (s, 2H), 4.32 (d, J=12.8 Hz, 2H), 4.26
(d, J=12.8 Hz, 2H), 3.75 (t, J=7.2 Hz, 4H), 3.71(t, J=7.2 Hz, 2H), 3.26
(m, 2H), 3.0 (m, 12H), 2.78 (m, 2H), 1.9–0.8 ppm (5m, 70H);
13C NMR ([D6]DMSO): d=169.4, 155.8, 151.3, 150.7, 150.4, 135.3, 135.1,
135.0, 135.0, 134.5, 134.2, 134.0, 118.8, 118.54, 118.5, 77.3, 76.6, 74.8, 31.6,
FTIR (KBr): n˜ =3333, 2931, 2858, 1653, 1559, 1213, 1042, 965 cmꢁ1
;
MALDI-FTMS: m/z: calcd for
C152H232N20O23Na: 2728.7491; found:
2728.7671[ M+Na]+; ESI-MS: m/z: calcd for C152H232N20O23Cl: 2741;
found: 2743 [M+Cl]ꢁ.
Biscalixarene (4): A mixture of 5 (2 g, 0.74 mmol), THF (25 mL), and
aqueous LiOH (1n, 10 mL) was stirred overnight at RT, after which H2O
(30 mL) was added, and the pH was adjusted to 6 with aqueous 1m HCl.
The product was extracted with CHCl3 (360 mL). The organic layer
was dried over Na2SO4 and evaporated to give the tetraurea acid (1.81 g,
5440
ꢀ 2004 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2004, 10, 5432 – 5442